Pre-close call
Logotype for Swedencare

Swedencare (SECARE) Pre-close call summary

Event summary combining transcript, slides, and related documents.

Logotype for Swedencare

Pre-close call summary

20 Mar, 2026

Market and Operational Update

  • No significant impact from Middle East turmoil or global transport disruptions; business as usual in key markets.

  • Demand remains stable and strong across Europe, the U.S., and globally, with ongoing monitoring of potential cost impacts.

  • Q4 profitability was affected by one-offs, including higher Amazon marketing costs, ERP implementation interruptions, and inventory write-offs, but these effects are expected to diminish going forward.

  • ERP implementation is now complete, improving production efficiency at the NaturVet site, with no further impact expected on gross margin or volumes.

  • Participation in major industry events like Global Pet Expo and Veterinary Meeting & Expo supports market presence.

Segment Performance and Sales Trends

  • North America and Europe show strong online sales and new product launches, with improving ROI on Amazon and robust demand in pet retail and veterinary channels.

  • Pet retail presence expanded to over 500 stores, with continued growth and new distribution partnerships.

  • Walmart sales increased week by week through February, driven by a Q4 display campaign.

  • European online and pet retail segments report strong demand, especially on Amazon, zooplus, and with strong starts in Italy and the UK.

  • Pharma, contract manufacturing, and private label segments started the year strong in the EU and UK, with US expected to improve in Q2.

Financial Outlook and Profitability

  • Double-digit annual organic growth achieved and targeted, with Q1 expected to meet this goal.

  • Gross margin improved to 58.1% in 2025 from Q4’s 56.8%, driven by better production and price increases.

  • EBITDA margin rose to 19.0% in 2025 from 15.9% in Q4, with improved profitability and no material one-offs expected in the current period.

  • Net debt/EBITDA ratio decreased to 2.9 compared to Q4, with ongoing debt amortization.

  • No significant one-off costs anticipated, and positive effects from scalability and price increases are expected.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more